At OC Wellness, we prescribe the No DAC (Drug Affinity Complex) formulation of CJC-1295 also known as Modified GRF (1-29)
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
Manufacturing is done in FDA registered facilities with proper quality control protocols
Together, they support vital body functions, helping reduce the risk of vitamin D deficiency, cognitive impairment, and fatigue especially in older adults, who are more vulnerable to low levels of these nutrients
Arch Neurol
KPV reduces the inflammatory background that can interfere with repair, while GHK-Cu directs the replacement work